122 related articles for article (PubMed ID: 25313253)
21. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.
Norrby-Teglund A; Muller MP; Mcgeer A; Gan BS; Guru V; Bohnen J; Thulin P; Low DE
Scand J Infect Dis; 2005; 37(3):166-72. PubMed ID: 15849047
[TBL] [Abstract][Full Text] [Related]
22. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
[TBL] [Abstract][Full Text] [Related]
23. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.
Valiquette L; Low DE; McGeer AJ
Clin Infect Dis; 2009 Nov; 49(9):1377-9. PubMed ID: 19788361
[No Abstract] [Full Text] [Related]
24. [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
Bosland A; Arlaud K; Rousset-Rouvière C; Fouilloux V; Paut O; Dubus JC; Bosdure E
Arch Pediatr; 2011 Dec; 18(12):1310-4. PubMed ID: 22041597
[TBL] [Abstract][Full Text] [Related]
25. [Indications for intravenous immunoglobulins].
Mouthon L
Presse Med; 2006 Apr; 35(4 Pt 2):714-9. PubMed ID: 16614620
[TBL] [Abstract][Full Text] [Related]
26. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
Baxter M; Morgan M
Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
[TBL] [Abstract][Full Text] [Related]
27. Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Rajagopalan G; Patel R; Kaveri SV; David CS
J Antimicrob Chemother; 2007 Jan; 59(1):157-9; author reply 159-60. PubMed ID: 17071954
[No Abstract] [Full Text] [Related]
28. Severe group A streptococcal infection and streptococcal toxic shock syndrome.
Baxter F; McChesney J
Can J Anaesth; 2000 Nov; 47(11):1129-40. PubMed ID: 11097546
[TBL] [Abstract][Full Text] [Related]
29. Plasmapheresis in streptococcal toxic shock syndrome.
Hoeper MM; Abou-Rebyeh F; Athman C; Schwarz A
Crit Care Med; 2001 Dec; 29(12):2399. PubMed ID: 11801855
[No Abstract] [Full Text] [Related]
30. Necrotizing fasciitis.
Cherneski CL; Embil JM
Saudi Med J; 2001 Jul; 22(7):565-8. PubMed ID: 11479634
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.
Kaul R; McGeer A; Norrby-Teglund A; Kotb M; Schwartz B; O'Rourke K; Talbot J; Low DE
Clin Infect Dis; 1999 Apr; 28(4):800-7. PubMed ID: 10825042
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Necrotizing Soft Tissue Infections: IVIG.
Madsen MB; Bergsten H; Norrby-Teglund A
Adv Exp Med Biol; 2020; 1294():105-125. PubMed ID: 33079366
[TBL] [Abstract][Full Text] [Related]
33. [The role of IVIG in treatment of generalized infections].
Lewandowicz-Uszyńska A
Postepy Hig Med Dosw; 2002; 56 Suppl():85-90. PubMed ID: 12661418
[TBL] [Abstract][Full Text] [Related]
34. Treatment of postoperative purulent pericarditis and streptococcal toxic shock syndrome by intensive blood purification.
Lin X; Shi XQ; Zha Y
Saudi Med J; 2014 Sep; 35(9):1154-6. PubMed ID: 25228196
[No Abstract] [Full Text] [Related]
35. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
Feigenberg T; Sela HY; Applbaum YH; Mankuta D
Isr Med Assoc J; 2008 Jun; 10(6):483-4. PubMed ID: 18669156
[No Abstract] [Full Text] [Related]
36. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
[TBL] [Abstract][Full Text] [Related]
37. A survey of physician's attitudes regarding management of severe group A streptococcal infections.
Valiquette L; Low DE; Chow R; McGeer AJ
Scand J Infect Dis; 2006; 38(11-12):977-82. PubMed ID: 17148064
[TBL] [Abstract][Full Text] [Related]
38. Streptococcal toxic shock associated with septic abortion.
Dotters DJ; Katz VL
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):549-51. PubMed ID: 1870820
[TBL] [Abstract][Full Text] [Related]
39. Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: case report and review.
Geller JL; Hackner D
Ann Hematol; 2005 Sep; 84(9):601-4. PubMed ID: 15815906
[TBL] [Abstract][Full Text] [Related]
40. Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin.
Al-Rawi S; Woodward LJ; Knight J
Int J Obstet Anesth; 2009 Apr; 18(2):169-72. PubMed ID: 19195874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
